Latest Insider Transactions at Orchard Therapeutics PLC (ORTX)
This section provides a real-time view of insider transactions for Orchard Therapeutics PLC (ORTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Orchard Therapeutics plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Orchard Therapeutics plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 24
2024
|
Charles A Rowland Jr |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,294
-100.0%
|
-
|
|
Jan 24
2024
|
Frank E Thomas |
SELL
Sale (or disposition) back to the issuer
|
Direct |
92,081
-100.0%
|
-
|
|
Jan 24
2024
|
James A Geraghty |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,391
-100.0%
|
-
|
|
Jan 24
2024
|
Joanne T. Beck |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,294
-100.0%
|
-
|
|
Jan 24
2024
|
Marc Dunoyer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,179
-100.0%
|
-
|
|
Jan 24
2024
|
Bobby Gaspar Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
366,158
-100.0%
|
-
|
|
Mar 10
2023
|
Frank E Thomas |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.84%
|
$0
$0.46 P/Share
|
|
Feb 09
2023
|
Frank E Thomas |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+21.72%
|
$0
$0.46 P/Share
|
|
Apr 01
2022
|
Bobby Gaspar Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+3.94%
|
$0
$0.74 P/Share
|
|
Apr 01
2022
|
Frank E Thomas |
BUY
Open market or private purchase
|
Direct |
10,000
+16.11%
|
$0
$0.75 P/Share
|
|
Feb 19
2021
|
Fmr LLC > 10% Shareholder |
SELL
Conversion of derivative security
|
Indirect |
819,704
-9.09%
|
-
|
|
Feb 05
2021
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,045,510
-16.71%
|
$12,273,060
$6.98 P/Share
|
|
Jan 29
2021
|
Frank E Thomas |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.2%
|
$20,000
$2.44 P/Share
|
|
Jan 11
2021
|
Bobby Gaspar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,411
-0.96%
|
$20,466
$6.72 P/Share
|
|
Jan 11
2021
|
Frank E Thomas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,706
-10.36%
|
$22,236
$6.72 P/Share
|
|
Jan 08
2021
|
Bobby Gaspar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+1.73%
|
-
|
|
Jan 08
2021
|
Frank E Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
10,667
+22.96%
|
-
|
|
Sep 24
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
473,327
+4.57%
|
$1,893,308
$4.61 P/Share
|
|
Aug 21
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
64,642
+0.34%
|
$258,568
$4.58 P/Share
|
|
Aug 20
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
62,631
+0.33%
|
$250,524
$4.61 P/Share
|
|
Aug 19
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
64,254
+0.34%
|
$257,016
$4.67 P/Share
|
|
Aug 18
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
45,249
+0.49%
|
$180,996
$4.72 P/Share
|
|
Aug 17
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
8,235
+0.09%
|
$32,940
$4.74 P/Share
|
|
Aug 14
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
13,031
+0.14%
|
$52,124
$4.74 P/Share
|
|
Aug 12
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
16,291
+0.18%
|
$65,164
$4.74 P/Share
|
|
Aug 10
2020
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
21,357
+0.12%
|
$85,428
$4.73 P/Share
|